Q3 2026
As of 9 Oct 2026
As of 9 Oct 2026
Evidence approved
77%
▲ +27 pts vs Q2 2026
The evidence approval rate rose from 50% in Q2 2026 to 77% in Q3 2026.
Investigate →Evidence not yet approved by owner team
evidence items pending or rejected · Q3 2026
- Unassigned 22 100%
Domains between periods
Fastest rise: Third-Party Risk (+2)
Each line is a control domain, from Q2 2026 to Q3 2026 (recorded values only). Red = rising, green = falling. Click a domain for its records.